These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

863 related articles for article (PubMed ID: 17198989)

  • 1. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family.
    Kyndt F; Probst V; Potet F; Demolombe S; Chevallier JC; Baro I; Moisan JP; Boisseau P; Schott JJ; Escande D; Le Marec H
    Circulation; 2001 Dec; 104(25):3081-6. PubMed ID: 11748104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long QT and Brugada syndrome gene mutations in New Zealand.
    Chung SK; MacCormick JM; McCulley CH; Crawford J; Eddy CA; Mitchell EA; Shelling AN; French JK; Skinner JR; Rees MI
    Heart Rhythm; 2007 Oct; 4(10):1306-14. PubMed ID: 17905336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3.
    Ruan Y; Denegri M; Liu N; Bachetti T; Seregni M; Morotti S; Severi S; Napolitano C; Priori SG
    Circ Res; 2010 Apr; 106(8):1374-83. PubMed ID: 20339117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological and trafficking defects of the SCN5A T353I mutation in Brugada syndrome are rescued by alpha-allocryptopine.
    Zhang J; Chen Y; Yang J; Xu B; Wen Y; Xiang G; Wei G; Zhu C; Xing Y; Li Y
    Eur J Pharmacol; 2015 Jan; 746():333-43. PubMed ID: 25261036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death.
    Rossenbacker T; Carroll SJ; Liu H; Kuipéri C; de Ravel TJ; Devriendt K; Carmeliet P; Kass RS; Heidbüchel H
    Heart Rhythm; 2004 Nov; 1(5):610-5. PubMed ID: 15851228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.
    Liu J; Bayer JD; Aschar-Sobbi R; Wauchop M; Spears D; Gollob M; Vigmond EJ; Tsushima R; Backx PH; Chauhan VS
    PLoS One; 2018; 13(5):e0197273. PubMed ID: 29791480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel.
    Wang DW; Crotti L; Shimizu W; Pedrazzini M; Cantu F; De Filippo P; Kishiki K; Miyazaki A; Ikeda T; Schwartz PJ; George AL
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):370-8. PubMed ID: 19808432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A homozygous SCN5A mutation in a severe, recessive type of cardiac conduction disease.
    Neu A; Eiselt M; Paul M; Sauter K; Stallmeyer B; Isbrandt D; Schulze-Bahr E
    Hum Mutat; 2010 Aug; 31(8):E1609-21. PubMed ID: 20564468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome.
    Petitprez S; Jespersen T; Pruvot E; Keller DI; Corbaz C; Schläpfer J; Abriel H; Kucera JP
    Cardiovasc Res; 2008 Jun; 78(3):494-504. PubMed ID: 18252757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies.
    Meregalli PG; Tan HL; Probst V; Koopmann TT; Tanck MW; Bhuiyan ZA; Sacher F; Kyndt F; Schott JJ; Albuisson J; Mabo P; Bezzina CR; Le Marec H; Wilde AA
    Heart Rhythm; 2009 Mar; 6(3):341-8. PubMed ID: 19251209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes.
    Deschênes I; Baroudi G; Berthet M; Barde I; Chalvidan T; Denjoy I; Guicheney P; Chahine M
    Cardiovasc Res; 2000 Apr; 46(1):55-65. PubMed ID: 10727653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome.
    Cordeiro JM; Barajas-Martinez H; Hong K; Burashnikov E; Pfeiffer R; Orsino AM; Wu YS; Hu D; Brugada J; Brugada P; Antzelevitch C; Dumaine R; Brugada R
    Circulation; 2006 Nov; 114(19):2026-33. PubMed ID: 17075016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel.
    Barajas-Martínez HM; Hu D; Cordeiro JM; Wu Y; Kovacs RJ; Meltser H; Kui H; Elena B; Brugada R; Antzelevitch C; Dumaine R
    Circ Res; 2008 Aug; 103(4):396-404. PubMed ID: 18599870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation.
    Keller DI; Acharfi S; Delacrétaz E; Benammar N; Rotter M; Pfammatter JP; Fressart V; Guicheney P; Chahine M
    J Mol Cell Cardiol; 2003 Dec; 35(12):1513-21. PubMed ID: 14654377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation in the SCN5A gene is associated with Brugada syndrome.
    Shin DJ; Kim E; Park SB; Jang WC; Bae Y; Han J; Jang Y; Joung B; Lee MH; Kim SS; Huang H; Chahine M; Yoon SK
    Life Sci; 2007 Jan; 80(8):716-24. PubMed ID: 17141278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs.
    Valdivia CR; Tester DJ; Rok BA; Porter CB; Munger TM; Jahangir A; Makielski JC; Ackerman MJ
    Cardiovasc Res; 2004 Apr; 62(1):53-62. PubMed ID: 15023552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Just another Brugada syndrome mutation?
    Napolitano C
    Heart Rhythm; 2007 Jan; 4(1):54-5. PubMed ID: 17198990
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardiac sodium channelopathy from bench to bedside].
    Zhang YM; Zhou N
    Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):874-7. PubMed ID: 24484568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 44.